Results of gamma knife radiosurgery in acromegaly

Alberto Franzin, Giorgio Spatola, Marco Losa, Piero Picozzi, Pietro Mortini

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment in acromegaly. We analyzed the safety and efficacy of GK in patients who had previously received maximal surgical debulking at our hospital. Methods. The study was a retrospective analysis of hormonal, radiological, and ophthalmologic data collected in a predefined protocol from 1994 to 2009. The mean age at treatment was 42.3 years (range 22-67yy). 103 acromegalic patients participated in the study. The median follow-up was 71 months (IQ range 43-107). All patients were treated with GK for residual or recurrent GH-secreting adenoma. Results. Sixty-three patients (61.2) reached the main outcome of the study. The rate of remission was 58.3 at 5 years (95 CI 47.6-69.0). Other 15 patients (14.6) were in remission after GK while on treatment with somatostatin analogues. No serious side effects occurred after GK. Eight patients (7.8) experienced a new deficit of pituitary function. New cases of hypogonadism, hypothyroidism, and hypoadrenalism occurred in 4 of 77 patients (5.2), 3 of 95 patients (3.2), and 6 of 100 patients at risk (6.0), respectively. Conclusion. In a highly selected group of acromegalic patients, GK treatment had good efficacy and safety.

Original languageEnglish
Article number342034
JournalInternational Journal of Endocrinology
Volume2012
DOIs
Publication statusPublished - 2012

Fingerprint

Acromegaly
Radiosurgery
Safety
Adrenal Insufficiency
Hypogonadism
Therapeutics
Hypothyroidism
Somatostatin
Adenoma
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Results of gamma knife radiosurgery in acromegaly. / Franzin, Alberto; Spatola, Giorgio; Losa, Marco; Picozzi, Piero; Mortini, Pietro.

In: International Journal of Endocrinology, Vol. 2012, 342034, 2012.

Research output: Contribution to journalArticle

@article{8d61ec8f57374b929f816c0756df491d,
title = "Results of gamma knife radiosurgery in acromegaly",
abstract = "Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment in acromegaly. We analyzed the safety and efficacy of GK in patients who had previously received maximal surgical debulking at our hospital. Methods. The study was a retrospective analysis of hormonal, radiological, and ophthalmologic data collected in a predefined protocol from 1994 to 2009. The mean age at treatment was 42.3 years (range 22-67yy). 103 acromegalic patients participated in the study. The median follow-up was 71 months (IQ range 43-107). All patients were treated with GK for residual or recurrent GH-secreting adenoma. Results. Sixty-three patients (61.2) reached the main outcome of the study. The rate of remission was 58.3 at 5 years (95 CI 47.6-69.0). Other 15 patients (14.6) were in remission after GK while on treatment with somatostatin analogues. No serious side effects occurred after GK. Eight patients (7.8) experienced a new deficit of pituitary function. New cases of hypogonadism, hypothyroidism, and hypoadrenalism occurred in 4 of 77 patients (5.2), 3 of 95 patients (3.2), and 6 of 100 patients at risk (6.0), respectively. Conclusion. In a highly selected group of acromegalic patients, GK treatment had good efficacy and safety.",
author = "Alberto Franzin and Giorgio Spatola and Marco Losa and Piero Picozzi and Pietro Mortini",
year = "2012",
doi = "10.1155/2012/342034",
language = "English",
volume = "2012",
journal = "International Journal of Endocrinology",
issn = "1687-8337",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Results of gamma knife radiosurgery in acromegaly

AU - Franzin, Alberto

AU - Spatola, Giorgio

AU - Losa, Marco

AU - Picozzi, Piero

AU - Mortini, Pietro

PY - 2012

Y1 - 2012

N2 - Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment in acromegaly. We analyzed the safety and efficacy of GK in patients who had previously received maximal surgical debulking at our hospital. Methods. The study was a retrospective analysis of hormonal, radiological, and ophthalmologic data collected in a predefined protocol from 1994 to 2009. The mean age at treatment was 42.3 years (range 22-67yy). 103 acromegalic patients participated in the study. The median follow-up was 71 months (IQ range 43-107). All patients were treated with GK for residual or recurrent GH-secreting adenoma. Results. Sixty-three patients (61.2) reached the main outcome of the study. The rate of remission was 58.3 at 5 years (95 CI 47.6-69.0). Other 15 patients (14.6) were in remission after GK while on treatment with somatostatin analogues. No serious side effects occurred after GK. Eight patients (7.8) experienced a new deficit of pituitary function. New cases of hypogonadism, hypothyroidism, and hypoadrenalism occurred in 4 of 77 patients (5.2), 3 of 95 patients (3.2), and 6 of 100 patients at risk (6.0), respectively. Conclusion. In a highly selected group of acromegalic patients, GK treatment had good efficacy and safety.

AB - Objective. Single-session radiosurgery with Gamma Knife (GK) may be a potential adjuvant treatment in acromegaly. We analyzed the safety and efficacy of GK in patients who had previously received maximal surgical debulking at our hospital. Methods. The study was a retrospective analysis of hormonal, radiological, and ophthalmologic data collected in a predefined protocol from 1994 to 2009. The mean age at treatment was 42.3 years (range 22-67yy). 103 acromegalic patients participated in the study. The median follow-up was 71 months (IQ range 43-107). All patients were treated with GK for residual or recurrent GH-secreting adenoma. Results. Sixty-three patients (61.2) reached the main outcome of the study. The rate of remission was 58.3 at 5 years (95 CI 47.6-69.0). Other 15 patients (14.6) were in remission after GK while on treatment with somatostatin analogues. No serious side effects occurred after GK. Eight patients (7.8) experienced a new deficit of pituitary function. New cases of hypogonadism, hypothyroidism, and hypoadrenalism occurred in 4 of 77 patients (5.2), 3 of 95 patients (3.2), and 6 of 100 patients at risk (6.0), respectively. Conclusion. In a highly selected group of acromegalic patients, GK treatment had good efficacy and safety.

UR - http://www.scopus.com/inward/record.url?scp=84858302031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84858302031&partnerID=8YFLogxK

U2 - 10.1155/2012/342034

DO - 10.1155/2012/342034

M3 - Article

VL - 2012

JO - International Journal of Endocrinology

JF - International Journal of Endocrinology

SN - 1687-8337

M1 - 342034

ER -